Unlock instant, AI-driven research and patent intelligence for your innovation.

Hydrophilic pyridine compound, intermediate and preparation method and application thereof

A compound and hydrophilic technology, applied in the field of hydrophilic pyridine compounds, can solve the problems of low dynamic range, target specificity to be improved, weak imaging signal of prostate cancer cells, etc.

Active Publication Date: 2019-01-08
昆山市如絮生物科技有限公司
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] The technical problem to be solved by the present invention is to solve the problems that the currently existing radiolabeled contrast agents have weak imaging signals for PSMA-expressing prostate cancer cells, the displayed dynamic range is low, and the specificity for the target needs to be improved. Thereby provide a kind of hydrophilic pyridine compound, intermediate, its preparation method and application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hydrophilic pyridine compound, intermediate and preparation method and application thereof
  • Hydrophilic pyridine compound, intermediate and preparation method and application thereof
  • Hydrophilic pyridine compound, intermediate and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0158] The preparation of embodiment 1 compound V---VIII

[0159]

[0160] General synthetic procedure: 1.0 mmol of substrates 1-4, 5.0 mmol of oxidizing agent H under general laboratory conditions 5 IO 6 , 0.2 mmol RuCl 3 Catalyst, add 100mL CCl 4 with 250mL of water. After stirring for 24 hours, the aqueous layer was collected and acidified to pH=1 with 3N HCl. The aqueous layer was then extracted with ethyl acetate and washed with Na 2 SO 4 Drying and evaporation of volatiles gave the product 0.40-0.60 mmol as a yellow grease (40-60% yield). 1 H NMR and MS data are consistent with literature reports. Add 5mL of thionyl chloride and reflux for 1-2 hours, drain the solvent, dissolve it with chloroform and filter, drain the solution quantitatively, and continue to use it.

Embodiment 2

[0161] The preparation of embodiment 2 compound IX-XVIII series

[0162]

[0163]

[0164] Compound IX-XVIII synthesis steps: 1.0mmol substrate, 1.0mmol piperidine, 5.0mL CH 3 CN, the reaction mixture was reacted at 80°C for 10-20 hours, and stirred until the reaction was completed. The reaction mixture was partitioned between ethyl acetate and saturated brine. The organic solvent phase was dried in magnesium sulfate, and the solvent was drained, and the crude product was separated on a silica gel column, using ethyl acetate and methanol (90-95:10-5, v / v) as the mobile phase. Among them, the raw substrates 5-10 are derived from the esterification of their respective diacids, and are not purified and separated.

Embodiment 3

[0165] The preparation of embodiment 3 compound I1_3AAA-I1_3DDD and II3_3AAA-II3_3DDD

[0166]

[0167] General synthetic procedure: 1.0 mmol substrate IV, 1.2 eq V, 3.0 eq pyridine, 5.0 mL CH 2 Cl 2 , and the reaction mixture was stirred at room temperature until the reaction was complete. The solvent was drained, and the crude product was separated with a silica gel column, using ethyl acetate and methanol (90-95:10-5, v / v) as the mobile phase.

[0168]

[0169] 1.0mmol substrate I1_3BBB or II3_3BBB, 5eq Me 3 N, 1.1 eq Me 3 SiOTf, 5.0 mL CH 2 Cl 2 , and the reaction mixture was stirred at room temperature until the reaction was complete. The solvent was drained, and the crude product was separated with a silica gel column, using ethyl acetate and methanol (90-95:10-5, v / v) as the mobile phase.

[0170] Compound I1_3AAA, yield 78%, purity >95%, 1 H NMR (400MHz; DMSO-d 6 ),δ12.2(brs,1H,CO 2 H),9.01(d, 3 J HH =8.9Hz,1H,Ar-H),8.01(d, 3 J HH =8.9Hz,1H,Ar-H),8....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a hydrophilic pyridine compound, an intermediate and a preparation method and the application thereof. The structure of the hydrophilic pyridine compound is as show in a formula, in which X is COOH, CONH2 or CONHC2H4NH2. The hydrophilic pyridine compound has a good bonding capability to a PSMA protein of a prostate cancer cell. The compound radiolabelled by 18F can be usedas a PSMA protein imaging developing agent which is applied to positron emission tomography (PET) so as to diagnose prostatic cancer or track the drug therapeutic effect.

Description

technical field [0001] The invention relates to a hydrophilic pyridine compound, an intermediate, a preparation method and application thereof. Background technique [0002] Prostate cancer (English: Prostate cancer) is a malignant tumor originating from human prostate tissue. Most prostate cancers grow slowly, but some grow quickly. Cancer cells can metastasize to places such as bones and lymph nodes. Prostate cancer may have no symptoms in the early stage, and may cause symptoms such as difficulty urinating, blood in the urine, back pain, and pelvic pain in the advanced stage. An enlarged prostate can cause similar symptoms. Late symptoms also include tiredness caused by low numbers of red blood cells in the blood. [0003] Risk factors for prostate cancer include advanced age, family history, and race. Patients are over 50 years of age in approximately 99% of cases. When relatives such as parents and brothers suffer from the disease, the risk of developing the disea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D213/82C07D213/81C07D213/79C07D213/80C07D213/803C07B59/00A61K51/04A61K101/02
CPCA61K51/0455C07B59/002C07B2200/05C07B2200/07C07D213/79C07D213/80C07D213/803C07D213/81C07D213/82Y02P20/55
Inventor 蔡玲玲蔡勇全
Owner 昆山市如絮生物科技有限公司